These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2983101

  • 1. Reassortant rotaviruses as potential live rotavirus vaccine candidates.
    Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM.
    J Virol; 1985 Mar; 53(3):949-54. PubMed ID: 2983101
    [Abstract] [Full Text] [Related]

  • 2. Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.
    Midthun K, Hoshino Y, Kapikian AZ, Chanock RM.
    J Clin Microbiol; 1986 Nov; 24(5):822-6. PubMed ID: 3021814
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML.
    Rev Infect Dis; 1989 Nov; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [Abstract] [Full Text] [Related]

  • 7. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
    Jin Q, Ward RL, Knowlton DR, Gabbay YB, Linhares AC, Rappaport R, Woods PA, Glass RI, Gentsch JR.
    Arch Virol; 1996 Nov; 141(11):2057-76. PubMed ID: 8973523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of the two rotavirus genes determining neutralization specificities.
    Offit PA, Blavat G.
    J Virol; 1986 Jan; 57(1):376-8. PubMed ID: 3001359
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
    Vesikari T, Varis T, Green K, Flores J, Kapikian AZ.
    Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genotypic diversity of reassortants between simian rotavirus SA11 and human rotaviruses having different antigenic specificities and RNA patterns.
    Kobayashi N, Kojima K, Taniguchi K, Urasawa T, Urasawa S.
    Res Virol; 1994 May; 145(5):303-11. PubMed ID: 7839008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model.
    Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK, Kapikian AZ.
    Virology; 1995 May 10; 209(1):274-80. PubMed ID: 7747480
    [Abstract] [Full Text] [Related]

  • 16. Effect of the selection pressure with anti-VP7 and anti-VP4 neutralizing monoclonal antibodies on reassortant formation between two human rotaviruses.
    Kobayashi N, Taniguchi K, Urasawa T, Urasawa S.
    Arch Virol; 1994 May 10; 135(3-4):383-96. PubMed ID: 7802855
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants.
    Clements-Mann ML, Makhene MK, Mrukowicz J, Wright PF, Hoshino Y, Midthun K, Sperber E, Karron R, Kapikian AZ.
    Vaccine; 1999 Jun 04; 17(20-21):2715-25. PubMed ID: 10418923
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.